ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,166.76
0.03%
Dow Jones
39,169.52
0.13%
Gold vs US Dollar
2,328.265
-0.17%
Brent Oil
86.685
0.18%
Bitcoin
63,077.13
0.36%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Lixte Biotechnology Holdings Inc (LIXTW) Share Price

LIXTW Lixte Biotechnology Holdings Inc

0.0597
0.00 (0.00%)
01 Jul 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Lixte Biotechnology Holdings Inc NASDAQ:LIXTW NASDAQ Equity Warrant  Warrant
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 0.0597 0.035 0.0849 0.00 0.00   20:02:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -5.09M -2.2619 -1.06 5.38M
 Type  Size  Price  Time  Units 
   0.00  
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore LIXTW News
14/06/202419:47EDGAR2Form 8-K - Current report
14/06/202416:00GLOBELIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial
14/06/202414:30GLOBELIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial
14/06/202413:30EDGAR2Form 8-K - Current report
06/06/202413:30GLOBEScientific Journal Reports Findings that Show LIXTE’s Lead Clinical Compound, LB-100, Increases Recognition of Colon Cancer Cells by the Immune System
05/06/202420:55EDGAR2Form 8-K - Current report
03/06/202413:30GLOBELIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer
Period
Draw mode
Data Downloads for LIXTW

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Lixte Biotechnology Holdings Inc Articles